Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase

British Journal of Cancer, Published online: 18 June 2019; doi:10.1038/s41416-019-0496-4Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase

Source: British Journal of Cancer - June 17, 2019 Category: Cancer & Oncology Authors: Maitreyee K. Jathal Thomas M. Steele Salma Siddiqui Benjamin A. Mooso Leandro S. D ’Abronzo Christiana M. Drake Young E. Whang Paramita M. Ghosh Source Type: research